Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors
- Authors
- Han, Y.; Han, M.; Shin, D.; Song, C.; Hahn, H.-G.
- Issue Date
- Sep-2012
- Publisher
- AMER CHEMICAL SOC
- Citation
- Journal of Medicinal Chemistry, v.55, no.18, pp.8188 - 8192
- Journal Title
- Journal of Medicinal Chemistry
- Volume
- 55
- Number
- 18
- Start Page
- 8188
- End Page
- 8192
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/17476
- DOI
- 10.1021/jm3008294
- ISSN
- 0022-2623
- Abstract
- Novel azetidines based on the 3-aryl-3-oxypropylamine scaffold were designed, synthesized, and evaluated as TRIs. Reduction of 1 followed by Swern oxidation and then Grignard reaction gave 3. The alkylation of 3 provided the corresponding azetidine derivatives 6, of which the two most promising, 6bd and 6be, were selected from 86 prepared analogues based on their biological profiles. Compound 6be showed activity in vivo in FST at 10 mg/kg IV or 20-40 mg/kg PO. © 2012 American Chemical Society.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 약학대학 > 약학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/17476)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.